Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Study of YOLT-203 in Children and Adults With Primary Hyperoxaluria Type 1 (PH1)Calculi, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Hyperoxaluria, Kidney Calculi, Male Urogenital Diseases, Nutritional and Metabolic Diseases, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Urinary Calculi, Urogenital Diseases, hereditary disease, inborn carbohydrate metabolic disorder, inborn errors of metabolism, kidney disorder, metabolic disease, nephrolithiasis, primary hyperoxaluria, primary hyperoxaluria type 1, urinary system disorder, urolithiasisRecruitingPhase 22026-10-09NCT07587021

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
YolTech Therapeutics Co., Ltd3

4 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Childrens Hospital of ColoradoAuroraUnited States6
University of Alabama at Birmingham (UAB Hospital)BirminghamUnited States1
University of Pennsylvania Health System (UPHS) - Penn MedicinePhiladelphiaUnited States1
Washington University/Barnes Jewish HospitalSt LouisUnited States1